Patents
Literature
4 results about "Reuptake inhibitor" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A reuptake inhibitor (RI) is a type of drug known as a reuptake modulator that inhibits the plasmalemmal transporter-mediated reuptake of a neurotransmitter from the synapse into the pre-synaptic neuron. This leads to an increase in extracellular concentrations of the neurotransmitter and an increase in neurotransmission. Various drugs exert their psychological and physiological effects through reuptake inhibition, including many antidepressants and psychostimulants.
Treatment of sleep disorders using triple reuptake inhibitors
PendingCN122094679ANervous disorderHeterocyclic compound active ingredientsTreatment sleepSleeping disorders
This article provides a method for treating sleep disorders (e.g., narcolepsy) in subjects who require it by administering a composition containing a triple reuptake inhibitor to the subject.
Owner:NOEMA PHARMA AG
Triple reuptake inhibitors used in the treatment of behavioral immune-metabolic cluster disorders or diseases
PendingCN122094680AFacilitated Diffusiondegree of reductionNervous disorderMetabolism disorderDiseaseReuptake inhibitor
Owner:NOEMA PHARMA AG
Compositions and Methods of Treating Neurological Conditions
Pharmaceutical compositions containing a dopamine Putamen reuptake inhibitor or a dopaminergic agonist, an adrenoceptor antagonist, and a pharmaceutically acceptable carrier, and methods for treating neurological diseases by administering the composition.
Owner:DRI BIOSCIENCES CORP